Latest Form 4 insider transactions

Silver Point Capital, L.P. and 2 others reported changes in beneficial ownership of STUDIO CITY INTERNATIONAL HOLDINGS Ltd common stock on October 6, 2026.

Ben Simon Wilder, Chief Operating Officer of Arqit Quantum Inc., sold 218 shares of common stock on October 6, 2026 for $24.19 per share.

Nicholas William Nilan, General Manager-US of Arqit Quantum Inc., sold 493 shares of common stock on October 6, 2026 for $24.19 per share.

Garth Ritchie, a Director of Arqit Quantum Inc., sold 118 shares of common stock on October 6, 2026 for $24.19 per share.

Patrick Willcocks, General Counsel of Arqit Quantum Inc., sold 555 shares of common stock on October 6, 2026 for $24.19 per share.

Paul Feenan, Chief Revenue Officer of Arqit Quantum Inc., sold 504 shares of common stock on October 6, 2026 for $24.19 per share.

Andrew Leaver, Chief Executive Officer of Arqit Quantum Inc., sold 2,398 shares of common stock on October 6, 2026 for $24.19 per share.

Benoit Dageville, a Director of Snowflake Inc., sold 50,000 shares of common stock on October 7, 2026 for $333.42 per share.

Elias Nader, a Director of Immersion Corp, received 17,217 shares of common stock on October 7, 2026.

Alex Haro, a Director of Life360, Inc., sold 50,000 shares of common stock on October 6, 2026.

William C Martin, Chief Strategy Officer and a Director of Immersion Corp, received 17,217 shares of common stock on October 7, 2026.

Emily Hoffman, a Director of Immersion Corp, received 17,217 shares of common stock on October 7, 2026.

Childress Frederick Wasch, a Director of Immersion Corp, received 17,217 shares of common stock on October 7, 2026.

Stephen Neeleman, FOUNDER AND VICE CHAIRMAN and a Director of Healthequity, Inc., reported a transaction in 1,095 shares of common stock on October 6, 2026.

Eric Singer, President and CEO and a Director of Immersion Corp, purchased 41,000 shares of common stock on October 7, 2026.

Michael Gathright, Chief Customer Officer of Healthequity, Inc., reported a transaction in 662 shares of common stock on October 6, 2026.

Karen Boone, a Director of CoreWeave, Inc., reported multiple transactions in common stock on October 6, 2026.

Nitin Agrawal, Chief Financial Officer of CoreWeave, Inc., sold 3 shares of common stock on October 6, 2026 for $88.60 per share.

Canyon Capital Advisors Llc and 2 others reported changes in beneficial ownership of Cbl & Associates Properties Inc common stock on October 6, 2026.

Control Empresarial de Capitales S.A. de C.V. reported changes in beneficial ownership of Talos Energy Inc. common stock on October 6, 2026.

Yury Gryzlov, CHIEF OPERATING OFFICER of Grid Dynamics Holdings, Inc., sold 4,849 shares of common stock on October 8, 2026 for $8.00 per share.

James M Lucania, EVP & CFO of Healthequity, Inc., reported a transaction in 2,822 shares of common stock on October 6, 2026.

Fernando Matt Borges Martins, a Director and 10% owner of CI&T Inc, purchased 15,745 shares of common stock on October 6, 2026.

Joseph Devivo, President & CEO and a Director of Butterfly Network, Inc., sold 35,790 shares of common stock on October 6, 2026 for $10.02 per share.

Jeffrey E. Eberwein, Chief Executive Officer, a Director and 10% owner of Hudson Global, Inc., sold 3,000 shares of common stock on October 6, 2026.

Brian Allen Carrico, Chief Executive Officer and a Director of Neuraxis, INC, purchased 268 shares of common stock on October 8, 2026 for $4.84 per share.

Scott Cutler, President and CEO and a Director of Healthequity, Inc., reported a transaction in 1,230 shares of common stock on October 6, 2026.

Thomas Joeseph Carrico, CRO, CCO, CPO of Neuraxis, INC, purchased 328 shares of common stock on October 8, 2026 for $4.84 per share.

Timothy Robert Henrichs, Chief Financial Officer of Neuraxis, INC, purchased 1,937 shares of common stock on October 8, 2026 for $4.84 per share.

Sanjeev Narula, Chief Financial & Bus. Officer of Phathom Pharmaceuticals, Inc., reported a transaction in 13,485 shares of common stock on October 6, 2026.